Literature DB >> 16972167

Do benzodiazepines mimic reverse-turn structures?

Masayuki Hata1, Garland R Marshall.   

Abstract

The role of benzodiazepine derivatives (BZD) as a privileged scaffold that mimics beta-turn structures (Ripka et al. (1993) Tetrahedron 49:3593-3608) in peptide/protein recognition was reexamined in detail. Stable BZD ring conformers were determined with MM3, and experimental reverse-turn structures were extracted from the basis set of protein crystal structures previously defined by Ripka et al. Ideal beta-turns were also modeled and similarly compared with BZD conformers. Huge numbers of conformers were generated by systematically scanning the torsional degrees of freedom for BZDs, as well as those of ideal beta-turns for comparison. Using these structures, conformers of BZDs were fit to experimental structures as suggested by Ripka et al., or modeled classical beta-turn conformers, and the root-mean-square deviation (RMSD) values were calculated for each pairwise comparison. Pairs of conformers with the smallest RMSD values for overlap of the four alpha-beta side-chain orientations were selected. All overlaps of BZD conformers with experimental beta-turns yielded one or more comparisons where the least RMSD was significantly small, 0.48-0.86 angstroms, as previously suggested. Utilizing a different methodology, the overall conclusion that benzodiazepines could serve as reverse-turn mimetics of Ripka et al. is justified. The least RMSD values for the overlap of BZDs and modeled classical beta-turns were also less than 1 angstrom. When comparing BZDs with experimental or classical beta-turns, the set of experimental beta-turns selected by Ripka et al. fit the BZD scaffolds better than modeled classical beta-turns; however, all the experimental beta-turns did not fit a particular BZD scaffold better. A single BZD ring conformation, and/or chiral orientation, can mimic some, but not all, of the experimental beta-turn structures. BZD has two central ring conformations and one chiral center that explains why the four variations of the BZD scaffold can mimic all types of beta-turn structure examined. It was found, moreover, that the BZD scaffold also mimics each of the nine clusters of experimental orientations of side chains of reverse turns in the Protein Data Bank, when the new classification scheme for the four side-chain directions (the relative orientations of alpha-beta vectors of residues i through i+3) was considered (Tran et al. (2005) J Comput-Aided Mol Des 19:551-566).

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16972167     DOI: 10.1007/s10822-006-9059-x

Source DB:  PubMed          Journal:  J Comput Aided Mol Des        ISSN: 0920-654X            Impact factor:   3.686


  24 in total

1.  The Protein Data Bank.

Authors:  H M Berman; J Westbrook; Z Feng; G Gilliland; T N Bhat; H Weissig; I N Shindyalov; P E Bourne
Journal:  Nucleic Acids Res       Date:  2000-01-01       Impact factor: 16.971

2.  Structural evidence for induced fit as a mechanism for antibody-antigen recognition.

Authors:  J M Rini; U Schulze-Gahmen; I A Wilson
Journal:  Science       Date:  1992-02-21       Impact factor: 47.728

3.  Synthesis of potent cyclic hexapeptide NK-1 antagonists. Use of a minilibrary in transforming a peptidal somatostatin receptor ligand into an NK-1 receptor ligand via a polyvalent peptidomimetic.

Authors:  R Hirschmann; W Yao; M A Cascieri; C D Strader; L Maechler; M A Cichy-Knight; J Hynes; R D van Rijn; P A Sprengeler; A B Smith
Journal:  J Med Chem       Date:  1996-06-21       Impact factor: 7.446

4.  Topological side-chain classification of beta-turns: ideal motifs for peptidomimetic development.

Authors:  Tran Trung Tran; Jim McKie; Wim D F Meutermans; Gregory T Bourne; Peter R Andrews; Mark L Smythe
Journal:  J Comput Aided Mol Des       Date:  2005-11-23       Impact factor: 3.686

Review 5.  Peptidomimetic design.

Authors:  A S Ripka; D H Rich
Journal:  Curr Opin Chem Biol       Date:  1998-08       Impact factor: 8.822

6.  Calibration of effective van der Waals atomic contact radii for proteins and peptides.

Authors:  H Iijima; J B Dunbar; G R Marshall
Journal:  Proteins       Date:  1987

7.  Syntheses of fused heterocyclic compounds and their inhibitory activities for squalene synthase.

Authors:  Takashi Miki; Masakuni Kori; Akira Fujishima; Hiroshi Mabuchi; Ryu ichi Tozawa; Masahira Nakamura; Yasuo Sugiyama; Hidefumi Yukimasa
Journal:  Bioorg Med Chem       Date:  2002-02       Impact factor: 3.641

8.  A revised set of potentials for beta-turn formation in proteins.

Authors:  E G Hutchinson; J M Thornton
Journal:  Protein Sci       Date:  1994-12       Impact factor: 6.725

9.  Three-dimensional structure of an angiotensin II-Fab complex at 3 A: hormone recognition by an anti-idiotypic antibody.

Authors:  K C Garcia; P M Ronco; P J Verroust; A T Brünger; L M Amzel
Journal:  Science       Date:  1992-07-24       Impact factor: 47.728

10.  NMR studies on the structure of some cyclic and linear antagonists of luteinizing hormone-releasing hormone (LHRH).

Authors:  D V Reddy; B Jagannadh; A S Dutta; A C Kunwar
Journal:  Int J Pept Protein Res       Date:  1995-07
View more
  5 in total

1.  Identification of small molecule inhibitors of cisplatin-induced hair cell death: results of a 10,000 compound screen in the zebrafish lateral line.

Authors:  Andrew J Thomas; Patricia Wu; David W Raible; Edwin W Rubel; Julian A Simon; Henry C Ou
Journal:  Otol Neurotol       Date:  2015-03       Impact factor: 2.311

2.  Ugi/aldol sequence: expeditious entry to several families of densely substituted nitrogen heterocycles.

Authors:  Zhigang Xu; Fabio De Moliner; Alexandra P Cappelli; Christopher Hulme
Journal:  Angew Chem Int Ed Engl       Date:  2012-06-29       Impact factor: 15.336

Review 3.  Structure-Based Design of Inhibitors of Protein-Protein Interactions: Mimicking Peptide Binding Epitopes.

Authors:  Marta Pelay-Gimeno; Adrian Glas; Oliver Koch; Tom N Grossmann
Journal:  Angew Chem Int Ed Engl       Date:  2015-06-26       Impact factor: 15.336

4.  Sequential Ugi reaction/base-induced ring closing/IAAC protocol toward triazolobenzodiazepine-fused diketopiperazines and hydantoins.

Authors:  Robby Vroemans; Fante Bamba; Jonas Winters; Joice Thomas; Jeroen Jacobs; Luc Van Meervelt; Jubi John; Wim Dehaen
Journal:  Beilstein J Org Chem       Date:  2018-03-14       Impact factor: 2.883

5.  Identification of highly selective type II kinase inhibitors with chiral peptidomimetic tails.

Authors:  Seo-Jung Han; Jae Eun Jung; Do Hee Oh; Minsup Kim; Jae-Min Kim; Kyung-Sook Chung; Hee-Soo Han; Jeong-Hun Lee; Kyung-Tae Lee; Hee Jin Jeong; In Ho Park; Eunkyeong Jeon; Jeon-Soo Shin; Dongkeun Hwang; Art E Cho; Duck-Hyung Lee; Taebo Sim
Journal:  J Enzyme Inhib Med Chem       Date:  2022-12       Impact factor: 5.756

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.